Norman G. Hoffmann, Ph.D.
Norman G. Hoffmann, Ph.D., founder of Evince Diagnostics, is a nationally and internationally recognized expert in the development of practical, scientifically sound assessment instruments and the evaluation of behavioral health treatment programs. His assessment instruments are used throughout the United States, Canada, and parts of Europe. The instruments include brief and comprehensive interviews for the identification of mental health and substance use disorders in accordance with current diagnostic criteria as well as treatment planning aids based on the ASAM Criteria.
He has provided consultation services on assessment and evaluation issues for state and federal agencies, corporations and public organizations in the US, Canada, Sweden, and Norway. A popular current area consists of assisting treatment programs in the implementation of empirically driven assessment and information systems to facilitate decision support, outcome documentation, and continuous quality improvement protocols.
Dr. Hoffmann led the team that developed the first placement criteria for multiple levels of care and was the lead author on the first American Society of Addiction Medicine patient placement criteria. His work on treatment evaluation provided evidence for the societal and financial benefits from addictions treatment and a foundation for empirically supported funding of treatment services. Dr. Hoffmann served on first joint accreditation panel for prisons, probation, and parole in the United Kingdom. His publications include more than 200 articles, book chapters, and other publications.
Dr. Hoffmann received his doctorate in clinical psychology from the University of Minnesota. Although employed largely in the private sector, his faculty appointments include the University of Texas Medical Branch, University of Minnesota, and Brown University. He is currently adjunct professor of psychology at Western Carolina University
For upcoming presentations and workshops, to schedule a workshop or presentation, or to get more information concerning consultations, please contact Dr. Hoffmann via evinceassessment@aol.com or by calling 828-454-9960.
- Career Highlights
- C.V.
Quantity
Unit Cost
1-10
$5.25
11-50
$5.00
51+
$4.75
The TAAD-5 is a brief structured interview designed to identify current alcohol and drug problems.
Benefits
- Initial impression of current substance use disorders in 10 minutes
- DSM-5 compatible
- Structure provides consistent documentation
- Can indicate need for more comprehensive assessment
Conditions Covered
- Alcohol use disorders
- Drug use disorder indications
Application
Quick preliminary assessment: All eleven DSM-5 criteria covered for alcohol and other drugs in a 20-minute interview.
Preliminary qualification by treatment outreach: The TAAD-5 can be administered over the phone as a computer prompted interview to verify that an individual has sufficient indications of a substance use disorder.
Initial triage of DUI/DWI offenders: The TAAD-5 is widely used to distinguish those offenders who are likely to require intensive treatment for a substance use disorder from those who are likely to benefit from brief interventions or educational programs.
Administration
- Time requirement from 10 to 15 minutes
- Paper option: purchase interview in booklet form www.changecompanies.net.
- Training on the use of the paper version available from Evince Diagnostics
- Purchased in packets of 25 interviews with summary form for scoring